tirzepatide risk Study flags need to monitor frailty risks with GLP-1 drugs for older adults How Tirzepatide Supports Cardiovascular Health

Within safe limits, yes

That constant background mental chatter about meals, snacks, and what to eat next fades into something occasional and manageable

Tirzepatide is a novel agent that acts as an agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, another incretin that lowers glucose and appetite

Because guessing with peptide medications is not a strategy

Conclusions In the SURMOUNT-1 study, tirzepatide was cost-efficient in the UK for weight management, demonstrating favourable economic outcomes relative to its efficacy in reducing body weight and improving BMI

Tirzepatide is a medication used for weight loss and to treat type 2 diabetes